Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Equity (2020 - 2025)

Arcutis Biotherapeutics has reported Return on Equity over the past 6 years, most recently at 0.09% for Q4 2025.

  • Quarterly results put Return on Equity at 0.09% for Q4 2025, up 80.0% from a year ago — trailing twelve months through Dec 2025 was 0.09% (up 80.0% YoY), and the annual figure for FY2025 was 0.09%, up 104.0%.
  • Return on Equity for Q4 2025 was 0.09% at Arcutis Biotherapeutics, up from 0.3% in the prior quarter.
  • Over the last five years, Return on Equity for ARQT hit a ceiling of 0.09% in Q4 2025 and a floor of 4.21% in Q3 2023.
  • Median Return on Equity over the past 5 years was 0.93% (2024), compared with a mean of 1.29%.
  • Biggest five-year swings in Return on Equity: plummeted -288bps in 2023 and later skyrocketed 307bps in 2024.
  • Arcutis Biotherapeutics' Return on Equity stood at 0.63% in 2021, then plummeted by -108bps to 1.3% in 2022, then crashed by -198bps to 3.87% in 2023, then soared by 77bps to 0.89% in 2024, then soared by 90bps to 0.09% in 2025.
  • The last three reported values for Return on Equity were 0.09% (Q4 2025), 0.3% (Q3 2025), and 0.66% (Q2 2025) per Business Quant data.